Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,302 warrant series at 1,050 companies. 778 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 4 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tranche A Warrants issued November 4, 2024 (amended September 2026) | $0.3970 | $55.3M | 6-K, Sep 25, 2026Dilution tabAs of Oct 12, 2026 | ||||||||
| Tranche B Warrants issued November 4, 2024 (amended September 2026) | $0.3970 | $55.3M | 6-K, Sep 25, 2026Dilution tabAs of Oct 12, 2026 | ||||||||
| Volpe Warrant (Warrant No. W-2, issued November 28, 2022) | $2.76 | $55.2M | 10-Q, Sep 28, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Yankowitz Warrant (Warrant No. W-2, issued November 28, 2022) | $2.76 | $55.2M | 10-Q, Sep 28, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Convertible Notes Warrants (Mudrick) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Initial Virgin Atlantic Warrants | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| MWC Options (Marcus Waley-Cohen) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Public Warrants (Broadstone exchange, EVTLW) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| SF Warrants (Imagination Aero) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Tranche A Warrants (January 2025 Offering) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Tranche B Warrants (January 2025 Offering) | $0.2895 | $55.0M | 20-F, Mar 24, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Tranche C Warrants (August 2026 registered direct) | $0.2895 | $55.0M | 424B5, Aug 10, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Representative's Warrants (Lucid Capital Markets) – March 2026 underwritten public offering | $4.17 | $54.6M | 10-K, Sep 28, 2026Dilution tabAs of Oct 30, 2026 | ||||||||
| Legacy warrants outstanding (pre-December 2024 series, not itemised) | $0.6233 | $54.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| April 2026 Common Investor Warrants ($8.25) | $0.9700 | $54.4M | 6-K EX-99.1, Sep 29, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| April 2026 Placement Agent Warrants ($9.00) | $0.9700 | $54.4M | 6-K EX-99.1, Sep 29, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| AIFirst Note Warrant (October/December 2025) | $0.8489 | $54.3M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| BTC PIPE Warrants (September 30, 2026) | $0.8489 | $54.3M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Haase-Dubosc Note Warrants (October 2025) | $0.8489 | $54.3M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Warrants (October 2026 Registered Direct) | $0.8489 | $54.3M | 8-K, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Private Placement Warrants (IAC IPO) | $0.8489 | $54.3M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Public Warrants (IAC IPO) | $0.8489 | $54.3M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded warrants issued pursuant to the Private Placement | $3.14 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B warrants issued pursuant to 2024 underwritten public offering | $3.14 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series C warrants issued pursuant to the Private Placement | $3.14 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants issued in connection with OrbiMed Loan Facility | $3.14 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Pre-funded warrants (all series, aggregate) | $0.4132 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Common Warrants (July 2025 Offering) | $0.4132 | $53.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Private Placement pre-funded warrants (Velan Capital Master Fund LP) | $0.2822 | $53.7M | S-3, Sep 9, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| Hercules Warrants (tranche 1A lender warrants) | $0.2822 | $53.7M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Private Placement Warrants (former Chenghe Acquisition I Co. sponsor warrants, assumed by FST Corp.) | $1.19 | $53.5M | 20-F, Apr 20, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Public Warrants (former Chenghe Acquisition I Co. IPO warrants, assumed by FST Corp.) | $1.19 | $53.5M | F-1/A, Jul 22, 2025Dilution tabAs of Oct 29, 2026 | ||||||||
| Lind Warrant (July 2, 2024 Lind Global Asset Management VIII LLC common stock purchase warrant) | $4.20 | $53.3M | 10-K, Mar 31, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Prefunded warrants (all series, 10-Q aggregate as of September 30, 2026) | $7.54 | $53.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A warrants (June 2025 follow-on offering) | $7.54 | $53.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C warrants (June 2025 follow-on offering) | $7.54 | $53.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| February 2026 Placement Agent Warrants | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Issued Pre-Funded Warrants (February 2026 Offering) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Investor Warrants | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Placement Agent Warrants | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Publicly Traded Warrants (COCHW) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| September 2025 Investor Warrants | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| September 2025 Placement Agent Warrants | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A-1 Warrants (February 2026 Offering) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A-2 Warrants (February 2026 Offering) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Shortfall Warrants (Meteora FPA Parties) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – August 2024 Term Loan December 2024 draw ($22.00) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – August 2024 Term Loan initial funding ($29.70) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – February 2024 Term Loan initial funding ($12.40) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – February 2024 Term Loan July 2024 draw ($22.50) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 |
ARBEArbe Robotics Ltd. Ordinary Shares$0.3970Last price
Tranche A Warrants issued November 4, 2024 (amended September 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.3M
ARBEArbe Robotics Ltd. Ordinary Shares$0.3970Last price
Tranche B Warrants issued November 4, 2024 (amended September 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.3M
NORDNordicus Partners Corporation$2.76Last price
Volpe Warrant (Warrant No. W-2, issued November 28, 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.2M
NORDNordicus Partners Corporation$2.76Last price
Yankowitz Warrant (Warrant No. W-2, issued November 28, 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.2M
EVTLVertical Aerospace Ltd.$0.2895Last price
Convertible Notes Warrants (Mudrick)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
Initial Virgin Atlantic Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
MWC Options (Marcus Waley-Cohen)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
Public Warrants (Broadstone exchange, EVTLW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
SF Warrants (Imagination Aero)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
Tranche A Warrants (January 2025 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
Tranche B Warrants (January 2025 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
EVTLVertical Aerospace Ltd.$0.2895Last price
Tranche C Warrants (August 2026 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$55.0M
POCIPrecision Optics Corporation, Inc.$4.17Last price
Representative's Warrants (Lucid Capital Markets) – March 2026 underwritten public offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.6M
QUCYMainz Biomed N.V. Ordinary Shares$0.6233Last price
Legacy warrants outstanding (pre-December 2024 series, not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.4M
YDDLOne and One Green Technologies. Inc Class A Ordinary Shares$0.9700Last price
April 2026 Common Investor Warrants ($8.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.4M
YDDLOne and One Green Technologies. Inc Class A Ordinary Shares$0.9700Last price
April 2026 Placement Agent Warrants ($9.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.4M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
AIFirst Note Warrant (October/December 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
BTC PIPE Warrants (September 30, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
Haase-Dubosc Note Warrants (October 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
Placement Agent Warrants (October 2026 Registered Direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
Private Placement Warrants (IAC IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
AMODAlpha Modus Holdings, Inc.$0.8489Last price
Public Warrants (IAC IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$54.3M
VRCAVerrica Pharmaceuticals Inc.$3.14Last price
Pre-funded warrants issued pursuant to the Private Placement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
VRCAVerrica Pharmaceuticals Inc.$3.14Last price
Series B warrants issued pursuant to 2024 underwritten public offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
VRCAVerrica Pharmaceuticals Inc.$3.14Last price
Series C warrants issued pursuant to the Private Placement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
VRCAVerrica Pharmaceuticals Inc.$3.14Last price
Warrants issued in connection with OrbiMed Loan Facility
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
MISTMilestone Pharmaceuticals Inc.$0.4132Last price
Pre-funded warrants (all series, aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
MISTMilestone Pharmaceuticals Inc.$0.4132Last price
Series B Common Warrants (July 2025 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.9M
HRTXHeron Therapeutics, Inc.$0.2822Last price
2023 Private Placement pre-funded warrants (Velan Capital Master Fund LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.7M
HRTXHeron Therapeutics, Inc.$0.2822Last price
Hercules Warrants (tranche 1A lender warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.7M
KBSXFST Corp. Ordinary Shares$1.19Last price
Private Placement Warrants (former Chenghe Acquisition I Co. sponsor warrants, assumed by FST Corp.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.5M
KBSXFST Corp. Ordinary Shares$1.19Last price
Public Warrants (former Chenghe Acquisition I Co. IPO warrants, assumed by FST Corp.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.5M
MRDNMeridian Holdings Inc.$4.20Last price
Lind Warrant (July 2, 2024 Lind Global Asset Management VIII LLC common stock purchase warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.3M
XLOXilio Therapeutics, Inc.$7.54Last price
Prefunded warrants (all series, 10-Q aggregate as of September 30, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.3M
XLOXilio Therapeutics, Inc.$7.54Last price
Series A warrants (June 2025 follow-on offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.3M
XLOXilio Therapeutics, Inc.$7.54Last price
Series C warrants (June 2025 follow-on offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.3M
COCHEnvoy Medical, Inc.$6.87Last price
February 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Issued Pre-Funded Warrants (February 2026 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
October 2025 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
October 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Publicly Traded Warrants (COCHW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
September 2025 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
September 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Series A-1 Warrants (February 2026 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Series A-2 Warrants (February 2026 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Shortfall Warrants (Meteora FPA Parties)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – August 2024 Term Loan December 2024 draw ($22.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – August 2024 Term Loan initial funding ($29.70)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – February 2024 Term Loan initial funding ($12.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – February 2024 Term Loan July 2024 draw ($22.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,302 series state an exercise price and 3,366 an expiry date. 121 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.